A Generic Double Whammy: Teva Pharmaceutical Industries Ltd (TEVA), Mylan Inc. (MYL)

Its narcolepsy drug Provigil saw generic competition from Par Pharmaceutical Companies, Inc. (NYSE:PRX) and Mylan Inc. (NASDAQ:MYL), causing sales of the branded drug to drop to $25 million in the fourth...... (read more)